Valuation: West Pharmaceutical Services, Inc.

Market Cap 26.96B 497B 24.04B 22.3B 20.31B 38.24B 2,562B 38.96B 268B 105B 1,335B 101B 99B 4,261B P/E 2026 *
44.7x
P/E 2027 * 38.8x
Enterprise Value 26.45B 487B 23.59B 21.89B 19.93B 37.52B 2,514B 38.23B 263B 103B 1,310B 99.24B 97.15B 4,181B EV / Sales 2026 *
7.84x
EV / Sales 2027 * 7.24x
Free-Float
92.88%
Yield 2026 *
0.24%
Yield 2027 * 0.25%
1 year 5,112.51
Extreme 5112.51
5,112.51
3 years 4,000
Extreme 4000
7,104.95
5 years 4,000
Extreme 4000
9,649
10 years 4,000
Extreme 4000
9,649
Manager TitleAgeSince
Chief Executive Officer 52 2026-08-30
Director of Finance/CFO 57 2025-08-03
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Director/Board Member 65 2011-01-31
Director/Board Member 69 2011-03-06
Director/Board Member 56 2012-02-11
Change 5-day change 1-year change 3-year change Capi.($)
+15.28%-.--% - - 26.37B
+2.29%+6.03%-21.45%+15.20% 178B
+1.29%+11.62%-1.13%+32.64% 121B
+4.12%+6.47%-20.75%+13.71% 108B
+0.41%+1.40%-45.37%-9.38% 75.7B
+1.56%+7.62%+7.39%+80.66% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+2.58%+7.55%+2.87%-25.10% 51.45B
+3.43%+8.00%-14.09%+28.39% 41.68B
+5.08%+4.05%+32.47%+15.12% 31.5B
Average +3.43%+3.49%-4.71%+23.43% 80.52B
Weighted average by Cap. +2.51%+4.21%-10.53%+22.28%

Financials

2026 *2027 *
Net sales 3.38B 62.2B 3.01B 2.79B 2.54B 4.79B 321B 4.88B 33.57B 13.14B 167B 12.66B 12.4B 533B 3.59B 66.11B 3.2B 2.97B 2.7B 5.09B 341B 5.18B 35.68B 13.97B 178B 13.46B 13.17B 567B
Net income 619M 11.4B 552M 512M 466M 878M 58.81B 894M 6.15B 2.41B 30.64B 2.32B 2.27B 97.8B 710M 13.08B 633M 587M 535M 1.01B 67.45B 1.03B 7.06B 2.76B 35.14B 2.66B 2.61B 112B
Net Debt -503M -9.27B -449M -416M -379M -714M -47.83B -727M -5.01B -1.96B -24.92B -1.89B -1.85B -79.55B -973M -17.94B -868M -805M -734M -1.38B -92.53B -1.41B -9.68B -3.79B -48.21B -3.65B -3.58B -154B
Projected Income Statement - Annual - West Pharmaceutical Services, Inc.
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - West Pharmaceutical Services, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
374.65USD
Average target price
412.88USD
Spread / Average Target
+10.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - West Pharmaceutical Services, Inc.